These researchers recently forced the expression of miRNA-328 in gastrointestinal cancer cell lines and found that CD44 expression was reduced, resulting in the repression of cancer cell growth in vitro and in vivo, and impaired resistance to ROS [98]. The gene discussed is CD44; the disease is cancer.